Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

Click for more information

0.00%

2.1¢ cann global limited

Ann: A World First for MCL in Autoimmune Disease Reasearch, page-275

First 275 Last

Share
Profile

Follow
Piouch

85 Posts.

23

05/03/18

21:25

Post #: 31541449
Share

Originally posted by Ryphil ↑

For now I'm going to assume your bona fides but I have some serious doubts.
Here are the points you need to remember imo regarding the MM and how it fits in:

1. QBL is waiting for approval to import Canntab expected in Mar/Apr...there should not be clinical trial issues with this for prescription because it is like prescribing cannabis except it is in pill form which makes the dosage much more accurate and controllable...that's the whole thinking behind the pill

2. Any serious MM player should be involved in research as well. You either have your own researchers or you have a research partner. Neither comes for free. QBL has chosen one of the best research partners there is (seriously, c'mon show us another ASX company that has this...). No one said this will lead to immediate or guaranteed income. But you can't wait for the discovery to happen and then buy in because then it's too late. The major opportunities must be ceased now while the industry is in its nascent phase.

3. The QBL research option imo is good value for money because it's $1m/year and the point we made earlier was that this research potential is anywhere as good as e.g. CAN has and CAN is in a similar position as QBL regarding development timeframes and phases, but already has a $450m+ market cap. CAN can supply medicinal cannabis but they cannot supply the Canntab, so again this sort of evens them out and yet CAN has a massive market cap.

4. Don't be penny wise and pound foolish. This research can also be a major source of positive announcements for QBL in addition to the building of the hemp business. And there is no other MM product developer on the ASX that can say they are also building a hemp business that is vertically integrated with major crops in Australia waiting to be harvested.

5. The company can afford the MM research out of existing cash imo (although they have indicated that might not be necessary because of funds available to the MCL subsidiary that signed the deal) because bauxite will only be developed if they get a proper offtake deal, and the hemp business will bring in substantial revenue imo, which is something that CAN for example will not have while they do product development or very little of.

Do yourself a favour and try and understand what the value drivers for the SP are.

Do your research properly before you come on here and puke out sheet as if it's fact.

In case you haven't been on HC long, imo it makes almost f'all difference to the SP and what happens on market as a result of what we post on here. The big boys have taken the market play of this stock long time ago.

But people come on here with *ed up motives and spread sheet all day long...that is what pisses me off...I don't expect someone like you to understand this until you have seen enough evidence of it for yourself.

Expand

Thanks mate I do appreciate the feedback and believe we got off on the wrong foot. Point 4 Is one that I did not consider and has been brought up twice now by yourself and another poster. I've seen the people with those motives on here and they destroy any credible conversation. Again thank you for your post.

QBL Price at posting: 4.8¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

There are more pages in this discussion • 4 more messages in this thread...

First 275 Last

Add CGB (ASX) to my watchlist

SPONSORED BY